Li S - Search Results

1

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.

Zeng Y, Ni J, Yu F, Zhou Y, Zhao Y, Li S, Guo T, Chu L, Yang X, Chu X, Cai X, Zhu Z. Zeng Y, et al. Among authors: li s. Radiat Oncol. 2020 Aug 27;15(1):207. doi: 10.1186/s13014-020-01651-y. Radiat Oncol. 2020. PMID: 32854745 Free PMC article.

2

Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.

Chu X, Li S, Xia B, Chu L, Yang X, Ni J, Zou L, Li Y, Xie C, Lin J, Zhu Z. Chu X, et al. Among authors: li s, li y. Radiat Oncol. 2019 Sep 18;14(1):171. doi: 10.1186/s13014-019-1371-4. Radiat Oncol. 2019. PMID: 31533763 Free PMC article.

3

Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.

Guo T, Ni J, Yang X, Li Y, Li Y, Zou L, Wang S, Liu Q, Chu L, Chu X, Li S, Ye L, Zhu Z. Guo T, et al. Among authors: li s, li y. Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):62-71. doi: 10.1016/j.ijrobp.2019.12.042. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987959

4

Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers.

Ni J, Guo T, Li Y, Yang X, Li Y, Zou L, Chu L, Chu X, Li S, Ye L, Zhang Y, Zhu Z. Ni J, et al. Among authors: li s, li y. Transl Lung Cancer Res. 2019 Dec;8(6):967-978. doi: 10.21037/tlcr.2019.12.02. Transl Lung Cancer Res. 2019. PMID: 32010575 Free PMC article.

5

Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.

Zhou Y, Wang B, Qu J, Yu F, Zhao Y, Li S, Zeng Y, Yang X, Chu L, Chu X, Li Y, Zou L, Guo T, Ye L, Liang F, Wang S, Liu Q, Ni J, Zhu Z. Zhou Y, et al. Among authors: li s, li y. Lung Cancer. 2020 Dec;150:178-185. doi: 10.1016/j.lungcan.2020.10.018. Epub 2020 Nov 5. Lung Cancer. 2020. PMID: 33186860

6

A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy.

Li S, Chu X, Ye L, Ni J, Zhu Z. Li S, et al. Transl Lung Cancer Res. 2020 Oct;9(5):2082-2096. doi: 10.21037/tlcr-20-512. Transl Lung Cancer Res. 2020. PMID: 33209628 Free PMC article. Review.

7

Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases.

Yu F, Ni J, Zeng W, Zhou Y, Guo T, Zeng Y, Zhao Y, Li S, Li Y, Yang X, Zou L, Wang S, Liu Q, Li Y, Chu L, Chu X, Ye L, Yu W, Zhu Z. Yu F, et al. Among authors: li s, li y. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):804-815. doi: 10.1016/j.ijrobp.2021.05.125. Epub 2021 May 29. Int J Radiat Oncol Biol Phys. 2021. PMID: 34058255

8

Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis.

Zhao Y, Li S, Yang X, Chu L, Wang S, Tong T, Chu X, Yu F, Zeng Y, Guo T, Zhou Y, Zou L, Li Y, Ni J, Zhu Z. Zhao Y, et al. Among authors: li s, li y. Int J Cancer. 2022 Apr 15;150(8):1318-1328. doi: 10.1002/ijc.33904. Epub 2022 Jan 6. Int J Cancer. 2022. PMID: 34914096

9

Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.

Zhou Y, Chu L, Li S, Chu X, Ni J, Jiang S, Pang Y, Zheng D, Lu Y, Lan F, Cai X, Yang X, Zhu Z. Zhou Y, et al. Among authors: li s. Cancer Immunol Immunother. 2024 Jun 4;73(8):141. doi: 10.1007/s00262-024-03725-2. Cancer Immunol Immunother. 2024. PMID: 38832974 Free PMC article.

10

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, Mate JL, Li S, Roig J, Olazábal A, et al. Rosell R, et al. Among authors: li s. N Engl J Med. 1994 Jan 20;330(3):153-8. doi: 10.1056/NEJM199401203300301. N Engl J Med. 1994. PMID: 8043059 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,537 results

Search Page

Filters